These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 11507037)

  • 1. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.
    Welsh JB; Sapinoso LM; Su AI; Kern SG; Wang-Rodriguez J; Moskaluk CA; Frierson HF; Hampton GM
    Cancer Res; 2001 Aug; 61(16):5974-8. PubMed ID: 11507037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.
    Rossi S; Graner E; Febbo P; Weinstein L; Bhattacharya N; Onody T; Bubley G; Balk S; Loda M
    Mol Cancer Res; 2003 Aug; 1(10):707-15. PubMed ID: 12939396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling reveals hepsin overexpression in prostate cancer.
    Magee JA; Araki T; Patil S; Ehrig T; True L; Humphrey PA; Catalona WJ; Watson MA; Milbrandt J
    Cancer Res; 2001 Aug; 61(15):5692-6. PubMed ID: 11479199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer.
    Stephan C; Yousef GM; Scorilas A; Jung K; Jung M; Kristiansen G; Hauptmann S; Kishi T; Nakamura T; Loening SA; Diamandis EP
    J Urol; 2004 Jan; 171(1):187-91. PubMed ID: 14665873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
    Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
    Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
    Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
    J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of prostate cancer biomarkers by microarray gene expression profiling.
    Sørensen KD; Ørntoft TF
    Expert Rev Mol Diagn; 2010 Jan; 10(1):49-64. PubMed ID: 20014922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Androgens and increased lipogenesis in prostate cancer. Cell biologic and clinical perspectives].
    Verhoeven G
    Verh K Acad Geneeskd Belg; 2002; 64(3):189-95; discussion 195-6. PubMed ID: 12238242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene expression profiling in prostatic cancer].
    Ernst T; Hergenhahn M; Kenzelmann M; Cohen CD; Ikinger U; Kretzler M; Hollstein M; Gröne HJ
    Verh Dtsch Ges Pathol; 2002; 86():165-75. PubMed ID: 12647366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z; Wenlu S
    Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.
    Chen Z; Fan Z; McNeal JE; Nolley R; Caldwell MC; Mahadevappa M; Zhang Z; Warrington JA; Stamey TA
    J Urol; 2003 Apr; 169(4):1316-9. PubMed ID: 12629351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
    Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D
    Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.
    Kristiansen G; Pilarsky C; Wissmann C; Kaiser S; Bruemmendorf T; Roepcke S; Dahl E; Hinzmann B; Specht T; Pervan J; Stephan C; Loening S; Dietel M; Rosenthal A
    J Pathol; 2005 Feb; 205(3):359-76. PubMed ID: 15532095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.
    Welsh JB; Sapinoso LM; Kern SG; Brown DA; Liu T; Bauskin AR; Ward RL; Hawkins NJ; Quinn DI; Russell PJ; Sutherland RL; Breit SN; Moskaluk CA; Frierson HF; Hampton GM
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3410-5. PubMed ID: 12624183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.
    Rose A; Xu Y; Chen Z; Fan Z; Stamey TA; McNeal JE; Caldwell M; Peehl DM
    Cancer Lett; 2005 Sep; 227(2):213-22. PubMed ID: 16112424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of prostate specific antigen (PSA) is negatively regulated by p53.
    Gurova KV; Roklin OW; Krivokrysenko VI; Chumakov PM; Cohen MB; Feinstein E; Gudkov AV
    Oncogene; 2002 Jan; 21(1):153-7. PubMed ID: 11791186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
    Fuessel S; Sickert D; Meye A; Klenk U; Schmidt U; Schmitz M; Rost AK; Weigle B; Kiessling A; Wirth MP
    Int J Oncol; 2003 Jul; 23(1):221-8. PubMed ID: 12792797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.